Woodcock: High Prices Create Problems For Entire Accelerated Approval Program

 
• By Sarah Karlin-Smith
  
price tag
High price tags are leading to opposition to FDA’s accelerated approval program, Woodcock says • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership